selected publications
-
Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.
Anesthesiology.
2016
Academic Article
GET IT
Times cited: 9 - Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat. Anesthesiology. 2016 Academic Article GET IT
-
NHE isoform switching and KChIP2 upregulation in aging porcine atria.
PloS one.
2013
Academic Article
GET IT
Times cited: 3 -
Transcriptomic analysis reveals atrial KCNE1 down-regulation following lung lobectomy.
Journal of molecular and cellular cardiology.
2012
Academic Article
GET IT
Times cited: 12 -
Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: pharmacodynamics, acute cardiovascular effects, and preliminary toxicology.
Anesthesiology.
2010
Academic Article
GET IT
Times cited: 13 -
Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs.
Anesthesiology.
2010
Academic Article
GET IT
Times cited: 14